riverment website
The RiverMend Health Website - 
RiverMend Health is a premier provider of evidence-based, scientifically driven addiction medicine delivering world-class treatment through our nationwide network of leading addiction recovery experts and treatment centers...

View Website

 

SAMHSA LOGO
The Substance Abuse and Mental Health Services Administration
(SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.

 

View Website

 

Cocaine’s effects on the heart can cause both immediate emergencies, such as a heart attack, and long-term damage.

Cocaine’s effects on the heart can cause both immediate emergencies, such as a heart attack, and long-term damage.

Regular, long-term cocaine use significantly increases the risk of heart disease. For people with pre-existing heart health problems, even short-term cocaine use may elevate the risk. These risks include…

Coronary artery disease

Higher blood pressure

Damage to the structure of the heart

Heart arrhythmias

Chest pain

Congestive heart failure

Heart attack and stroke

For complete article

In recent decades the range and patterns of opioids used for extra-medical purposes have changed. The use of pharmaceutical opioids exceeds the use of heroin. In 2017, 63 percent of opioid deaths were attributed exclusively to pharmaceutical opioids, 28 percent to illicit opioids and 8 percent to both illicit and pharmaceutical opioids (aged 15-64 years).

The objective of this report was to estimate the social costs arising from extra-medical opioid use in Australia for the financial year 2015/16. Due to data limitations in most cases we only estimated the costs occurring in this 12-month period. For example, on-going care of chronic conditions was not included. The exceptions to this were for certain harms which occurred in 2015/16 but which had longer-term ramifications, for example premature deaths, where discounted streams of future costs (lost economic activity and lost contributions to household chores) and partially offsetting savings (future health expenditure ’avoided’ by premature deaths) were estimated. The authors also included the long-term costs of road traffic accidents, as were the expected future costs of opioid attributable imprisonment for those sentenced in 2015/16.

For complete report go to APO - Quantifying the social costs of pharmaceutical opioid misuse

Policy Reflection – Dalgarno Institute: The misuse of OST (Opioid Substitute Treatments) or MAT (Medically Assisted Treatments) or any other pharmaceutical displacement mechanism that does not have a sunset clause to usage, will continue to be a major contributor to both morbidity and mortality. This can either occur over a longer time simply due to the toxic nature of persistent opioid use on the human biological unit; or short term, by direct  misuse of the legal opioid for ‘recreational’ or self-harming purposes, by either the client or their network. 

This growing issue continues to be overlooked or deliberately discounted by certain sectors. Which means that this, arguably well-meaning, but poorly implemented ‘harm reduction’ mechanism continues to add to the drug using cohort and the increasing harms this ‘pairing’ collectively bring. 

The net result of a no-exit, perpetual use of opioids, whether licit or illicit, only causes harm, the very thing the policy pillar was supposed to reduce.

If sunset clauses and exit strategies are not harnessed to these chemical mechanisms, then we will only see these harms grow, along with an ever-burgeoning pressure and cost to the health-care system. This is not best practice health care, and no longer rates as a positive ‘net community benefit’ economic rationale either

Reducing drug use is the primary objective of the National Drug Strategy, and in both its intent and specifics does not promote, or we would argue, condone this policy and people failing measure.

Drug use exiting recovery is not only possible, but consistently achieved when actively facilitated in its best practice format too. 

We will leave you with a very provocative quote (now 14 years old) but perhaps even more relevant today? A statement that could have only been published then, but with the  ‘cancel culture outrage’ in play at present, may well be ignored now and for the very reasons it confronts.

“The medical profession and the addicted community have a complex, symbiotic, mutually dependent relationship that does none of us any good. Basically, they pretend to be ill and we pretend to treat them. And thousands of public employees make a good living out of it. Prescribing for opiate addicts is like throwing petrol on a fire; pointless, counterproductive, stupid, self-defeating. And yet we keep doing it.”

Dr Phil Peverley, PULSE, 22 June 2006

As of January 7, 2020, a total of 2558 hospitalized patients with nonfatal cases and 60 patients with fatal cases of e-cigarette, or vaping, product use–associated lung injury (EVALI) had been reported to the Centers for Disease Control and Prevention (CDC).

CONCLUSIONS: Chronic conditions, including cardiac and respiratory diseases and mental health conditions, were common among hospitalized patients with EVALI.

Read More

Soaring rates of vaping among young people and associated problems have resulted in great urgency and important challenges for policymakers. Despite the urgency, policies should be evidence-based and thoughtfully designed. They require effective, collaborative, and well-funded enforcement by federal and state governments. Policymakers should aim to reduce vaping among young people while maintaining avenues to help smokers quit. Finally, policies should be forward-thinking, since the e-cigarette market is rapidly changing and e-cigarette companies can be more agile than regulators.

Published March 25, 2020, at NEJM.org. DOI:  10.1056/NEJMp1917065   

Featured Website

World Federation Against Drugs

World Federation Against Drugs (W.F.A.D) Dalgarno Institute is a member of this global initiative. For evidence based data on best practice drug policy in the global context.
Featured Website
Alt Tag

Institute for Behavior and Health

The Institute for Behavior and Health, Inc. is to reduce the use of illegal drugs. We work to achieve this mission by conducting research, promoting ideas that are affordable and scalable...
Featured Website

Drug Free Australia

Drug Free Australia Website. Drug Free Australia is a peak body, representing organizations and individuals who value the health and wellbeing of our nation...
Featured Website

Drug Advisory Council of Australia (D.A.C.A)

Drug Advisory Council of Australia (D.A.C.A) Dalgarno Institute is an executive member of this peak body. For updates on current illicit drug issues.
Featured Website

International Task Force on Strategic Drug Policy

(I.T.F.S.D.P) This international peak body continues to monitor and influence illicit drug policy on the international stage. Dalgarno Institute is a member organisation.
Featured Website

Smart Approaches to Marijuana

Smart Approaches to Marijuana. SAM's leaders are among the world's most prominent voices calling for science-based marijuana education and awareness.

21 Be There

There isn’t merely data sharing - it isn't about promoting a 'one dimensional' legislative solution to a complex problem
Featured Website

Drug Free Futures

Drug Policy Futures believes in engaging in an open dialogue about the strengths and weaknesses of global drug policies...
Featured Website

Action Alcohol

The National Alliance for Action on Alcohol is a national coalition of health and community organisations from across Australia that has been formed with the goal of reducing alcohol-related harm.
Featured Website

Greater Risk

Greater Risk Website - The younger they start the greater the risk...
Featured Website

Rivermend Health

RiverMend Health is a premier provider of scientifically driven, specialty behavioral health services to those suffering from alcohol and drug dependency, dual disorders, eating disorders, obesity and chronic pain.
Featured Website

Evidence-Based Practices Resource Center

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.
Featured Website

SAMHSA

SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.